186 related articles for article (PubMed ID: 23740425)
1. The importance of multimodality therapy in the treatment of sinonasal neuroendocrine carcinoma.
van der Laan TP; Bij HP; van Hemel BM; Plaat BE; Wedman J; van der Laan BF; Halmos GB
Eur Arch Otorhinolaryngol; 2013 Sep; 270(9):2565-8. PubMed ID: 23740425
[TBL] [Abstract][Full Text] [Related]
2. Sinonasal malignancies with neuroendocrine differentiation: case series and review of literature.
Menon S; Pai P; Sengar M; Aggarwal JP; Kane SV
Indian J Pathol Microbiol; 2010; 53(1):28-34. PubMed ID: 20090218
[TBL] [Abstract][Full Text] [Related]
3. Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype.
Rosenthal DI; Barker JL; El-Naggar AK; Glisson BS; Kies MS; Diaz EM; Clayman GL; Demonte F; Selek U; Morrison WH; Ang KK; Chao KS; Garden AS
Cancer; 2004 Dec; 101(11):2567-73. PubMed ID: 15517582
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: The importance of differentiation grade in determining treatment strategy.
van der Laan TP; Iepsma R; Witjes MJ; van der Laan BF; Plaat BE; Halmos GB
Oral Oncol; 2016 Dec; 63():1-9. PubMed ID: 27938993
[TBL] [Abstract][Full Text] [Related]
5. Survival outcomes in sinonasal carcinoma with neuroendocrine differentiation: A NCDB analysis.
Issa K; Ackall F; Jung SH; Li J; Jang DW; Rangarajan SV; Abi Hachem R
Am J Otolaryngol; 2021; 42(2):102851. PubMed ID: 33385873
[TBL] [Abstract][Full Text] [Related]
6. Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses.
Babin E; Rouleau V; Vedrine PO; Toussaint B; de Raucourt D; Malard O; Cosmidis A; Makaeieff M; Dehesdin D
J Laryngol Otol; 2006 Apr; 120(4):289-97. PubMed ID: 16526967
[TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of 31 patients with sinonasal neuroendocrine carcinoma].
Peng J; Li X; Liu Z; Cui Z; Jin H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jan; 36(1):32-35. PubMed ID: 34979616
[No Abstract] [Full Text] [Related]
8. Multimodality treatment for sinonasal neuroendocrine carcinoma.
Mitchell EH; Diaz A; Yilmaz T; Roberts D; Levine N; DeMonte F; Hanna EY; Kupferman ME
Head Neck; 2012 Oct; 34(10):1372-6. PubMed ID: 22052583
[TBL] [Abstract][Full Text] [Related]
9. Sinonasal neuroendocrine carcinoma: a population-based analysis of incidence and survival.
Patel TD; Vazquez A; Dubal PM; Baredes S; Liu JK; Eloy JA
Int Forum Allergy Rhinol; 2015 May; 5(5):448-53. PubMed ID: 25727332
[TBL] [Abstract][Full Text] [Related]
10. Patterns of failure after combined-modality approaches incorporating radiotherapy for sinonasal undifferentiated carcinoma of the head and neck.
Chen AM; Daly ME; El-Sayed I; Garcia J; Lee NY; Bucci MK; Kaplan MJ
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):338-43. PubMed ID: 18207030
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis, prognosis and treatment of sinonasal carcinomas (excluding melanomas, sarcomas and lymphomas)].
Thariat J; Moya Plana A; Vérillaud B; Vergez S; Régis-Ferrand F; Digue L; Even C; Costes V; Baujat B; de Gabory L; Baglin AC; Janot F;
Bull Cancer; 2020 May; 107(5):601-611. PubMed ID: 32305127
[TBL] [Abstract][Full Text] [Related]
12. Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): The Mayo Clinic Experience.
Gamez ME; Lal D; Halyard MY; Wong WW; Vargas C; Ma D; Ko SJ; Foote RL; Patel SH
Head Neck; 2017 Sep; 39(9):1819-1824. PubMed ID: 28561906
[TBL] [Abstract][Full Text] [Related]
13. Sinonasal undifferentiated carcinoma: clinical and pathologic features and a discussion on classification, cellular differentiation, and differential diagnosis.
Ejaz A; Wenig BM
Adv Anat Pathol; 2005 May; 12(3):134-43. PubMed ID: 15900114
[TBL] [Abstract][Full Text] [Related]
14. Sinonasal undifferentiated carcinoma: the search for a better outcome.
Musy PY; Reibel JF; Levine PA
Laryngoscope; 2002 Aug; 112(8 Pt 1):1450-5. PubMed ID: 12172261
[TBL] [Abstract][Full Text] [Related]
15. High-Grade Neuroendocrine Carcinoma of the Larynx: The Mayo Clinic Experience.
Deep NL; Ekbom DC; Hinni ML; Zarka MA; Patel SH
Ann Otol Rhinol Laryngol; 2016 Jun; 125(6):464-9. PubMed ID: 26611246
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine Carcinoma and Sinonasal Undifferentiated Carcinoma.
Abdelmeguid AS; Bell D; Hanna EY
Adv Otorhinolaryngol; 2020; 84():168-184. PubMed ID: 32731236
[TBL] [Abstract][Full Text] [Related]
17. Sinonasal Small Cell Carcinoma-Case Series of a Rare Malignancy.
Chapurin N; Totten DJ; Louis PC; Lewis JS; Chowdhury NI; Turner J; Chandra RK
Ear Nose Throat J; 2022 Jul; 101(6):392-395. PubMed ID: 33090899
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes and prognostic factors, including human papillomavirus, for sinonasal undifferentiated carcinoma: a retrospective review.
Gray ST; Herr MW; Sethi RK; Diercks G; Lee L; Curry W; Chan A; Clark J; Holbrook EH; Rocco J; Sadow PM; Lin DT
Head Neck; 2015 Mar; 37(3):366-74. PubMed ID: 24421248
[TBL] [Abstract][Full Text] [Related]
19. Sinonasal neuroendocrine carcinoma: impact of differentiation status on response and outcome.
Likhacheva A; Rosenthal DI; Hanna E; Kupferman M; Demonte F; El-Naggar AK
Head Neck Oncol; 2011 Jul; 3():32. PubMed ID: 21794118
[TBL] [Abstract][Full Text] [Related]
20. Does sophisticated diagnostic workup on neuroectodermal tumors have an impact on the treatment of esthesioneuroblastoma?
Haas I; Ganzer U
Onkologie; 2003 Jun; 26(3):261-7. PubMed ID: 12845211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
